Search results

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

See details of previously published customer updates from our Health products team. 

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

Read about an ANSTO scientist and their work to prepare for a school project or interview.

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.  

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

ANSTO contributes to new international project to improve how the world assesses the economic viability of Small Modular Reactors

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.

The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

nandin is ANSTO’s Innovation Centre where science and technology entrepreneurs, startups and graduates meet industry expertise to experiment, co-create, innovate, and commercialise, creating new jobs in the high-growth industries of tomorrow.